Abbott Molecular competitors

Zippia score 4.3

Abbott Molecular main competitors are Genentech, Illumina, and PacBio.

Competitor Summary. See how Abbott Molecular compares to its main competitors:

Genentech has the most employees (13,638).
Employees at Genentech earn more than most of the competitors, with an average yearly salary of $97,473.

Work at Abbott Molecular?

Share your experience

Abbott Molecular vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Abbott Molecular	1989	4.3	Des Plaines, IL	1	$74.5M	125
Serologicals Proteins Inc	-	4.1	Kankakee, IL	1	$350.0M	651
Sanofi Genzyme	1981	4.8	Cambridge, MA	1	$4.6B	12,000
Caliper Life Sciences	1995	4.5	Hopkinton, MA	1	$109.8M	200
Genentech	1976	4.5	South San Francisco, CA	5	$166.9M	13,638
Medimmune	1987	4.7	Gaithersburg, MD	1	$422.2M	6,030
Namsa	1967	4.2	Northwood, OH	5	$13.0M	142
Celera	1998	4.4	Alameda, CA	1	-	750
Morphotek	2000	3.7	Exton, PA	1	$4.8M	1
McNeil Consumer Healthcare	1879	4.3	Fort Washington, PA	1	$46.2M	17
Illumina	1998	4.8	San Diego, CA	5	$4.4B	7,800
Halyard Health	2014	4.4	Alpharetta, GA	3	$1.6B	11,000
Emergent BioSolutions	1998	4.8	Gaithersburg, MD	12	$1.6B	1,834
Instrumentation Laboratory	1959	4.8	Bedford, MA	2	$1.0B	3,000
Advanced Sterilization Products	1987	4.5	Irvine, CA	1	$83.0M	1,074
PacBio	2004	4.7	Menlo Park, CA	1	$154.0M	400
Regeneron	1988	4.9	Tarrytown, NY	7	$14.2B	9,123
Bio-Rad Laboratories	1952	4.7	Hercules, CA	4	$2.8B	8,250
Luminex	1995	4.7	Austin, TX	3	$417.4M	1,140
Promega	1978	4.7	Madison, WI	2	$450.0M	1,601
Cytori Therapeutics	1996	4.3	San Diego, CA	2	$7.4M	12

Rate Abbott Molecular's competitiveness in the market.

Abbott Molecular salaries vs competitors

Among Abbott Molecular competitors, employees at Genentech earn the most with an average yearly salary of $97,473.

Compare Abbott Molecular salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Abbott Molecular	$83,246	$40.02	-
Serologicals Proteins Inc	$44,917	$21.59	-
Sanofi Genzyme	$84,495	$40.62	-
Caliper Life Sciences	$81,030	$38.96	-
Genentech	$97,473	$46.86	-
Medimmune	$78,540	$37.76	-

Compare Abbott Molecular job title salaries vs competitors

Company	Highest salary	Hourly salary
Abbott Molecular	$73,483	$35.33
Genentech	$109,452	$52.62
Regeneron	$98,870	$47.53
Sanofi Genzyme	$94,952	$45.65
Bio-Rad Laboratories	$86,532	$41.60
Advanced Sterilization Products	$81,526	$39.20
Instrumentation Laboratory	$79,023	$37.99
Halyard Health	$76,894	$36.97
Namsa	$75,353	$36.23
McNeil Consumer Healthcare	$74,032	$35.59
Emergent BioSolutions	$73,826	$35.49
Medimmune	$71,638	$34.44
Serologicals Proteins Inc	$70,562	$33.92
Luminex	$70,079	$33.69
Celera	$66,728	$32.08
Promega	$64,667	$31.09
Illumina	$64,665	$31.09
Morphotek	$60,944	$29.30
Caliper Life Sciences	$54,943	$26.42
Cytori Therapeutics	$54,738	$26.32

Do you work at Abbott Molecular?

Does Abbott Molecular effectively differentiate itself from competitors?

Abbott Molecular jobs

Abbott Molecular demographics vs competitors

Compare gender at Abbott Molecular vs competitors

Job title	Male	Female
Emergent BioSolutions	56%	44%
Luminex	59%	41%
Abbott Molecular	60%	40%
Bio-Rad Laboratories	60%	40%
Illumina	62%	38%
PacBio	65%	35%

Male

Female

100%

75%

50%

25%

Emergent BioSolutions

25%

50%

75%

100%

Compare race at Abbott Molecular vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Abbott Molecular	60%	11%	11%	14%	4%	8.4
Bio-Rad Laboratories	47%	18%	7%	22%	6%	9.8
Emergent BioSolutions	60%	11%	16%	9%	4%	9.6
Illumina	46%	23%	7%	20%	5%	9.7
Luminex	48%	23%	11%	14%	3%	9.8
PacBio	42%	20%	5%	27%	5%	9.6

Abbott Molecular and similar companies CEOs

CEOBio

Norman D. Schwartz

Bio-Rad Laboratories

Mr. Norman D. Schwartz is Chairman of the Board, President, Chief Executive Officer of Bio Rad Laboratories Inc. Mr. Schwartz has been President and Chief Executive Officer since 2003 and Chairman of the Board since 2012. He was Vice President from 1989 to 2002, Group Manager, Life Science, from 1997 to 2002 and Group Manager, Clinical Diagnostics, from 1993 to 1997.

Marc Hedrick

Cytori Therapeutics

Robert Kramer Sr.

Emergent BioSolutions

Robert Kramer is a President & Chief Executive Officer at EMERGENT BIOSOLUTIONS INC., Board Member at EMERGENT BIOSOLUTIONS INC., and Interim Exec VP:Services at EMERGENT BIOSOLUTIONS INC. and is based in Lansing, Michigan. He has experience at PHARMACIA CORP and has worked as Pres:Biosciences Div at EMERGENT BIOSOLUTIONS INC., Consultant at EMERGENT BIOSOLUTIONS INC., and President at Emergent Biodefense Ops Lansg. Robert works or has worked as Chief Executive Officer at Emergent Biodefense Operations. He studied at WESTERN KENTUCKY UNIVERSITY between 1980 and 1983 and Clemson University between 1975 and 1979.

Robert Abernathy

Halyard Health

Francis A. Desouza

Illumina

Francis Aurelio deSouza (born December 2, 1970) is an American entrepreneur and business executive. He is the president and chief executive officer (CEO) of Illumina and a member of the Board of Directors of The Walt Disney Company.

Nachum Shamir

Luminex

With a proven track record of bringing game-changing technologies to the market, Mr. Shamir joined Luminex Corporation as President, Chief Executive Officer, and Board Member in 2014. From 2006 to 2014, Mr. Shamir served as President and CEO of Given Imaging, a developer, manufacturer, and marketer of diagnostic products for the visualization and detection of disorders of the gastrointestinal tract, which was acquired by Covidien PLC in early 2014. Mr. Shamir currently serves on the board of directors of Exalenz Bioscience Ltd. (TASE: EXEN). He has previously served as a Board Member at Scitex Corporation, Cogentix Medical (NASDAQ: CGNT), recently acquired by Laborie Medical Technologies, and invendo medical GmBH, now part of Ambu. Mr. Shamir holds a Bachelor of Science from the Hebrew University of Jerusalem and a Masters of Public Administration from Harvard University.

Christian O. Henry

PacBio

Alexander Hardy

Genentech

Alexander Hardy is the CEO of Genentech. Hardy, who joined Genentech in 2005, has served as CEO since March 1, 2019. He previously served as head of global product Strategy for Roche Pharmaceuticals. Previously, he headed up Asia Pacific for Roche's pharma outfit.

Paul Hudson

Sanofi Genzyme

Speck Loe

Medimmune

Speck Loe works at Medimmune and a Ceo at Medimmune and is based in Granite Falls, Washington.